Inogen, Inc. (INGN)

Market Cap	163.52M
Revenue (ttm)	315.66M
Net Income (ttm)	-102.45M
Shares Out	23.33M
EPS (ttm)	-4.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185,045
Open	6.97
Previous Close	6.95
Day's Range	6.77 - 7.20
52-Week Range	4.13 - 14.10
Beta	1.08
Analysts	Hold
Price Target	7.50 (+7.14%)
Earnings Date	May 7, 2024

About INGN

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Si...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 14, 2014
• Employees: 834
• Stock Exchange: NASDAQ
• Ticker Symbol: INGN

Financial Performance

In 2023, Inogen's revenue was $315.66 million, a decrease of -16.32% compared to the previous year's $377.24 million. Losses were -$102.45 million, 22.3% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for INGN stock is "Hold." The 12-month stock price forecast is $7.5, which is an increase of 7.14% from the latest price.

Price Target

$7.5

(7.14% upside)

Analyst Consensus: Hold